Navigation Links
David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
Date:3/17/2009

Joins Two Noted Cardiothoracic Surgeons to Lead Pivotal Trial

ANN ARBOR, Mich., March 17 /PRNewswire/ -- Terumo Heart Inc. today announced that it has appointed David Seth Feldman, MD/PhD, FACC, FAHA to be the Co-Principal Investigator for its Bridge-to-Transplant trial in the United States, studying the new, third generation DuraHeart(TM) Left Ventricular Assist System (LVAS). Dr. Feldman joins Dr. Francis Pagani, Director of the Heart Transplant and Center for Circulatory Support at University of Michigan, and Dr. Yoshifumi Naka, Director of cardiac transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center, in this role.

Dr. Feldman is Director of Heart Failure and Cardiac Transplantation and Director of Heart Failure and Transplant Fellowship Program at The Ohio State University Medical Center. He is Associate Professor of Medicine and Cardiology, with joint faculty positions in physiology and cell biology; Integrated Biological Program and the School of Pharmacy. A renowned heart failure cardiologist, Dr. Feldman holds numerous leadership positions within The Ohio State University, including the Heart Lung Research Institute, Transplant Consortium and Congestive Heart Failure Guidelines Implementation Committee, as well as the National Merit Review Grants-Cardiovascular Section and International Program Committee of the International Society of Heart and Lung Transplantation. Additionally, Dr. Feldman is a reviewer for leading American and European journals and is a molecular biologist with an actively funded NIH Laboratory. He has authored more than 50 peer-reviewed articles and eight book chapters. Dr. Feldman has held leadership roles in 26 clinical trials, as well as presented in numerous national and international medical meetings.

"I am excited to be part of this trial designed to offer new treatment options for patients w
'/>"/>

SOURCE Terumo Heart Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
2. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
3. Cancer Research David Hopes to Slay Cancer Goliath
4. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
5. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
6. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
7. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
8. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
9. /C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/
10. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
11. Fort Worth Surgeon Chosen as Investigator in Clinical Trial for Weight-Loss Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  AMETEK, Inc. (NYSE: ... Kurtis L. Goos as Vice President and ... Interconnects and Packaging (EMIP) Division. "I am ... general management and business development experience, especially in the ... important contributions to the continued growth and success of ...
(Date:7/25/2014)... , July 25, 2014 Leading ... is returning for the seventh year to São Paulo, ... 7 th August 2014. The event will co-locate with ... most comprehensive meeting point for the pharmaceutical industry. ... top 25 countries for pharmaceutical sales are now exploring the ...
(Date:7/25/2014)... July 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... corporate update and report second quarter 2014 financial results ... August 1, 2014. That same day, Arena will host ... Time (5:30 a.m. Pacific Time). The ... domestic callers and 914.495.8552 for international callers. Please specify ...
Breaking Medicine Technology:AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3
... WIRE)--Apr 3, 2007 - Allon,Therapeutics Inc. ... the publication of new preclinical data ... Allon's product,candidate AL-108 significantly reduces the ... of tau protein in the brain,two ...
... 03, 2007 /PRNewswire/ -- Southern,Research Institute, a not-for-profit ... areas of preclinical drug,discovery and drug development today ... presentation and 10 poster,presentations at the 2007 American ... in Los Angeles, Calif. , Anshu Mittal Roy ...
Cached Medicine Technology:Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 2Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 3Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 2Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 3
(Date:7/25/2014)... NC (PRWEB) July 25, 2014 Researchers at ... the results of a study indicating that a man-made material ... mesothelioma among workers exposed to asbestos. Surviving Mesothelioma has just ... to read it now. , The French scientists ... developed mesothelioma between 1987 and 2006. One group of ...
(Date:7/25/2014)... 25, 2014 Healthpointe is proud ... clinic is offering Occupational Medicine services to the ... accepting referrals and workers’ compensation cases. , ... clinic include wound care treatment management, return-to-work and ... pre-employment screening & physicals, and illness and injury ...
(Date:7/25/2014)... the leading pan-European association representing medical oncology professionals, ... Data Protection Regulation [1] could make cancer research ... doctors and cancer patients. , The proposed wording ... patient consent, meaning that researchers would have to ... in order to consult their data or use ...
(Date:7/25/2014)... Yisrayl Hawkins, Pastor and Overseer of The House of Yahweh ... revealing to the whole world, including even the most devout ... in his new article. , Yisrayl says it all started ... by the Catholic Church. He says this plan included removing ... and replacing it with titles such as Lord and God. ...
(Date:7/25/2014)... According to the Addict Him To You Pdf ... guide that teaches women how to get the love of ... its review that this book consists of 4 parts, including:, ... won’t commit yet (and what to do about it) , ... ,     Part 3: How to touch his heart ...
Breaking Medicine News(10 mins):Health News:New Study Shows Mesothelioma Risk is Higher in Workers Exposed to Man-Made Insulator, According to Surviving Mesothelioma 2Health News:New Study Shows Mesothelioma Risk is Higher in Workers Exposed to Man-Made Insulator, According to Surviving Mesothelioma 3Health News:Healthpointe Offering Occupational Medicine Services in La Mirada 2Health News:Is Europe putting cancer research at risk? 2Health News:Yisrayl Hawkins Says You Have Been Tricked Into Worshipping Satan in New Article 2Health News:Addict Him To You Pdf Review Exposes Mirabelle Summers' Dating Guide – Vkool.com 2Health News:Addict Him To You Pdf Review Exposes Mirabelle Summers' Dating Guide – Vkool.com 3
... -- A program that helps elementary school students develop ... science and cultural studies may be one way to ... United States. In a new study, researchers assessed ... in which students explore, prepare and enjoy fresh, affordable ...
... 2011 A two-year study of patients in the ... (TAVR) in patients who have severe aortic stenosis and ... one-year findings and support the role of TAVR as ... today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) ...
... NOVEMBER 10, 2011 Results of the PARTNER ... replacement (TAVR) results in improved quality of life compared ... the transfemoral approach. The results of the study were ... (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. ...
... thinking about Parkinson,s disease is that it,s a disorder of ... brain,s substantia nigra to die or become impaired. A study ... a hereditary form of Parkinson,s disease cause mitochondria to run ... to stop them. Findings appear in the November 11 issue ...
... physicians for increasing the volume of visits and procedures ... health outcomes," the American College of Physicians (ACP) today ... Pensions (HELP) in a hearing on Improving Quality, Lowering ... does not provide incentives for physicians to coordinate care; ...
... News) -- All the color variations seen in prehistoric ... populations, which indicates that the ancient human artists accurately ... The research is also the first to provide ... Previous DNA studies produced evidence only for bay (reddish ...
Cached Medicine News:Health News:Cooking Class Benefits Kids in Many Ways 2Health News:Results of the PARTNER Trial Cohort B 2-year follow up presented at TCT 2011 2Health News:Quality of life benefits of transcatheter aortic valve replacement differ by access site 2Health News:Why do neurons die in Parkinson's disease? 2Health News:Internists express strong support for ACA's programs to support coordinated care 2Health News:Cave Art Accurately Depicted Horses of Different Colors 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: